Publish Time: 2026-06-17 Origin: Site
Cerisflora™ Tart Cherry Concentrate Powder is a flagship product from World-Way Biotech, crafted from the world’s most extensively researched tart cherry variety — Montmorency (Prunus cerasus). This premium botanical extract delivers three clinically validated core benefits: uric acid stabilization and gout management, accelerated exercise recovery, and natural sleep enhancement. The red to purple-red powder is standardized to ≥10% polyphenols with 2-4% flavonoids, enriched with bioactive anthocyanins, quercetin, proanthocyanidins, and remarkably high levels of natural melatonin (13.46±1.10 ng/g — six times higher than conventional tart cherry varieties).
Tart cherry (Prunus cerasus), a member of the Rosaceae family, originated in Western Asia and the Black Sea coastal region. Today, its cultivated and hybrid varieties span nearly 40 countries across Europe, North America, and Asia. Among all tart cherry cultivars, Montmorency stands as the gold standard, backed by the largest body of scientific research and delivering superior concentrations of antioxidant polyphenols and bioactive melatonin.
Historically, North American indigenous peoples used tart cherry to alleviate joint pain and improve sleep. European traditional medicine also employed it for gout and inflammatory conditions. Modern clinical research has validated these traditional applications while uncovering the precise molecular mechanisms of action. The extract is derived exclusively from the fruit, ensuring a complete and authentic phytochemical profile.
Cerisflora™’s multi-target health benefits are powered by a comprehensive array of bioactive compounds:
Polyphenols (≥10%): Including anthocyanins (responsible for the vivid red-purple color and potent antioxidant activity), flavonols (such as quercetin), proanthocyanidin B2, phenolic acids (p-coumaric acid, chlorogenic acid), and ascorbic acid.
Natural Melatonin (13.46±1.10 ng/g): Six times higher than standard tart cherry varieties, with excellent oral bioavailability.
Three Core Mechanisms:
Mechanism 1 — Uric Acid Regulation & Gout Management:
Inhibition of Production: Significantly suppresses hepatic xanthine oxidase (XO) and xanthine dehydrogenase (XDH) activity, blocking the conversion of hypoxanthine to uric acid.
Promotion of Excretion: Human studies confirm that tart cherry consumption reduces serum uric acid while simultaneously increasing urinary uric acid excretion, demonstrating a unique dual-action approach.
Potent Anti-Inflammatory & Analgesic Action: Blocks both COX-1 and COX-2 enzymes, with an IC50 against COX-2 of just 1.5-3.2 mg/ml (versus 9.2-16.4 mg/ml for sweet cherry). Additionally, achieves 60% in vitro suppression of IL-1β secretion — the key inflammatory driver of acute gout attacks.
Mechanism 2 — Exercise Recovery:
Reduces Oxidative Damage: Clinical data shows significantly lower protein carbonyl (PC) levels post-exercise in tart cherry-supplemented groups, indicating reduced oxidative protein damage.
Minimizes Muscle Micro-Damage: Significantly reduces post-exercise CK-MB peak levels, attenuating inflammatory responses and delayed-onset muscle soreness (DOMS).
Mechanism 3 — Sleep Enhancement:
Clinical Validation: Liu (2018) demonstrated that tart cherry supplementation increased total sleep time by approximately 84 minutes in older adults, with significant improvement in sleep efficiency as measured by the Pittsburgh Sleep Quality Index (PSQI).
Versus Sweet Cherry: Tart cherry demonstrates dramatically superior anti-inflammatory potency, with a COX-2 IC50 of 1.5-3.2 mg/ml compared to sweet cherry’s 9.2-16.4 mg/ml.
Versus Conventional Uric Acid-Lowering Drugs: Allopurinol only inhibits uric acid production (XO inhibition), while benzbromarone only promotes excretion. Tart cherry uniquely combines both mechanisms — inhibition of production AND promotion of excretion — offering a more comprehensive approach without the long-term hepatorenal side effects associated with pharmaceutical interventions. In animal studies, tart cherry’s uric acid-lowering effects trended comparably with positive drug controls (febuxostat/allopurinol).
Cerisflora™ is manufactured in a Class 100,000 high-standard cleanroom, using only purified water as the extraction solvent with zero chemical solvent residues throughout the entire process. The core工艺流程 includes raw material inspection, extraction, filtration, purification, vacuum concentration, ultra-high temperature (UHT) sterilization, spray drying, milling, three-dimensional mixing, and sieving.
The ultrasound-assisted medium-temperature extraction ensures high efficiency with short processing times. Vacuum concentration significantly reduces working temperatures to protect heat-sensitive anthocyanins, while rapid spray drying and UHT flash sterilization preserve the natural flavor profile and ensure consistent physical properties.
The product is manufactured under a comprehensive quality system certified to KOSHER, HALAL, FSSC 22000, and ISO 9001 international standards. Routine third-party testing by Eurofins covers over 300 pesticide residues and heavy metal parameters, ensuring full compliance with the highest international safety standards. Alkemist Labs HPTLC analysis confirms 100% botanical identity, with sample fingerprints perfectly matching Prunus cerasus reference standards.
Recommended daily dose: 500-1,000 mg. Versatile application formats include tablets/pressed candies, hard capsules, powdered drink mixes, gummies, ready-to-drink beverages (oral liquids), and snack foods.
Within World-Way Biotech’s product matrix, Cerisflora™ is precisely positioned across three high-growth market segments: Joint Health (Uric Acid Management), Sports Nutrition, and Sleep Enhancement. As a clinically validated, multi-certified premium botanical ingredient, Cerisflora™ has emerged as one of the company’s flagship cross-border e-commerce dietary supplement ingredients, widely embraced by global health brands and formulators.
• Gout and hyperuricemia patients seeking natural daily uric acid management and acute flare relief
• Business professionals with high-purine dietary habits and frequent alcohol consumption
• Athletes and fitness enthusiasts requiring accelerated post-exercise muscle recovery and DOMS relief
• Individuals with sleep disorders related to chronic stress, anxiety, or circadian rhythm disruption
• Health-conscious consumers seeking clinically validated, multi-benefit natural supplements
Cerisflora™ Tart Cherry Concentrate Powder represents a paradigm shift in natural health ingredients. Built on the world’s most scientifically validated Montmorency tart cherry variety, produced through pristine water-only extraction and purification, and backed by rigorous international certifications, this ingredient delivers clinically proven benefits across three interconnected health domains: uric acid management, exercise recovery, and sleep quality. Its unique dual-action mechanism on uric acid — simultaneously inhibiting production and promoting excretion — sets it apart from both single-pathway pharmaceuticals and generic tart cherry extracts. As global consumer demand for natural, multi-functional, and clinically substantiated health solutions continues to accelerate, Cerisflora™ is strategically positioned to lead the next generation of evidence-based botanical ingredients in the joint health, sports nutrition, and sleep wellness markets.